Fortis nets tidy profit as it walks away from Parkway deal
This article was originally published in Scrip
Executive Summary
Fortis Healthcare of India has agreed to divest its entire holding in the Singapore hospital operator, Parkway, to the Malaysian state investor, Khazanah Nasional, bowing out of what could have turned into a bidding war between the two for control of Parkway.
You may also be interested in...
Biocon Biologics CEO Makes Surprise Exit
The CEO of Biocon’s biosimilars subsidiary has unexpectedly departed the role. Management stresses there is no disruption to its "strategic intent", but COVID-19 has "dampened" the arm’s push to reach its aspirational $1bn revenue target by 2022.
Prices Plunge As Xarelto Generics Arrive In India
More than half a dozen generic rivaroxaban brands are now available in India, putting the heat on Bayer’s blockbuster anticoagulant Xarelto in the price-sensitive market. Many rival generics are priced over 50% lower than the innovator product.
Dr Reddy’s Wants To Break Into Top Five In India
Dr Reddy’s signals a sharp step up in ambitions at home, propelled by building leadership in 10 therapy segments and an “India-first” approach for specialty products. Uptick in the China business and the potential launch of a Russia-partnered COVID-19 vaccine were other aspects of the business discussed at JPM.
Need a specific report? 1000+ reports available
Buy Reports